Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.6%

1 terminated/withdrawn out of 61 trials

Success Rate

97.6%

+11.1% vs industry average

Late-Stage Pipeline

20%

12 trials in Phase 3/4

Results Transparency

10%

4 of 40 completed trials have results

Key Signals

9 recruiting4 with results

Enrollment Performance

Analytics

N/A

15(44.1%)

Phase 3

11(32.4%)

Phase 2

7(20.6%)

Phase 4

1(2.9%)

34Total

N/A(15)

Phase 3(11)

Phase 2(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (61)

Showing 20 of 61 trials

NCT04235816Phase 3Active Not Recruiting

Improving Care Through Azithromycin Research for Infants in Africa

Role: lead

NCT06833957Recruiting

Preparing for Maternal GBS Vaccine Trials in Africa

Role: lead

NCT06064591Completed

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

Role: collaborator

NCT05047315Completed

Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV

Role: lead

NCT06426147Not ApplicableRecruiting

L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

Role: lead

NCT06422338Not ApplicableRecruiting

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Role: lead

NCT05085340Completed

MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention

Role: lead

NCT06841614Phase 3Not Yet Recruiting

EBOla Post-Exposure Prophylaxis

Role: collaborator

NCT07356817Recruiting

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

Role: collaborator

NCT07312266Recruiting

Questioning the Epidemiology of Asymptomatic TB

Role: lead

NCT06622629Not ApplicableCompleted

Nature Based Therapy With Mindful Walks in Urban Coastal Setting - Barcelona (Spain)

Role: lead

NCT05124691Phase 2Terminated

Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms

Role: lead

NCT03915366Phase 2Completed

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Role: collaborator

NCT06282315Phase 3Recruiting

Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness

Role: collaborator

NCT03762239Not ApplicableCompleted

Effect of Air Pollution on the Cognitive Function of Adolescents

Role: lead

NCT05868005Not ApplicableCompleted

Delivering a Multi-disease Screening Tool to Migrant Populations

Role: lead

NCT06743698Not Yet Recruiting

META Trial - a Mixed Methods Process Evaluation

Role: collaborator

NCT04746729Recruiting

Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy

Role: collaborator

NCT04568967Not ApplicableCompleted

TB-CAPT EXULTANT - HIV

Role: collaborator

NCT06907563Not Yet Recruiting

Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Role: collaborator